|
CMTM1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.84101689027739E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.93340000004461E-06 |
| Normal-vs-Stage2 |
1.179540E-02 |
| Normal-vs-Stage3 |
7.385200E-04 |
| Normal-vs-Stage4 |
3.490100E-02 |
| Stage1-vs-Stage2 |
5.301600E-01 |
| Stage1-vs-Stage3 |
2.353600E-01 |
| Stage1-vs-Stage4 |
4.375200E-01 |
| Stage2-vs-Stage3 |
7.313200E-01 |
| Stage2-vs-Stage4 |
7.872000E-01 |
| Stage3-vs-Stage4 |
9.967400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.83539969281321E-10 |
| Normal-vs-AfricanAmerican |
4.003100E-04 |
| Normal-vs-Asian |
2.007600E-01 |
| Caucasian-vs-AfricanAmerican |
4.721200E-01 |
| Caucasian-vs-Asian |
6.368000E-01 |
| AfricanAmerican-vs-Asian |
8.068800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.21839998885088E-09 |
| Normal-vs-Female |
3.12760000009682E-07 |
| Male-vs-Female |
1.663980E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.036400E-03 |
| Normal-vs-Extreme_Weight |
1.625170E-04 |
| Normal-vs-Obese |
3.52230000000286E-06 |
| Normal-vs-Extreme_Obese |
4.149200E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.585800E-01 |
| Normal_Weight-vs-Obese |
1.548370E-02 |
| Normal_Weight-vs-Extreme_Obese |
3.239400E-01 |
| Extreme_Weight-vs-Obese |
7.037700E-03 |
| Extreme_Weight-vs-Extreme_Obese |
3.524800E-01 |
| Obese-vs-Extreme_Obese |
4.021600E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.923000E-03 |
| Normal-vs-Age(41-60Yrs) |
1.13259956968648E-10 |
| Normal-vs-Age(61-80Yrs) |
3.5783000000067E-05 |
| Normal-vs-Age(81-100Yrs) |
1.559250E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.157000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.770300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.100150E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.872200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.65759999999949E-05 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.721900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.67089997183245E-09 |
| Normal-VS-Type2 PRCC |
4.164200E-04 |
| Normal-VS-KIRP CIMP |
1.460110E-03 |
| Normal-VS-Unclassified PRCC |
1.684960E-03 |
| Type1 PRCC-VS-Type2 PRCC |
8.882000E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.94002999999165E-05 |
| Type1 PRCC-VS-Unclassified PRCC |
1.784980E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.463400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
4.877600E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.534300E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.382100E-03 |
| Normal-vs-N1 |
4.778500E-04 |
| Normal-vs-N2 |
1.065640E-01 |
| N0-vs-N1 |
2.175900E-02 |
| N0-vs-N2 |
2.172800E-01 |
| N1-vs-N2 |
8.312400E-01 |
|
|
